© 2000 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Altered paracrine effect of endothelin in blood vessels of the hyperinsulinemic, insulin resistant obese Zucker rat
Department of Pharmacology and the Cardiovascular Risk Factor Reduction Unit, College of Medicine, University of Saskatchewan, 107 Wiggins Rd., Saskatoon, SK, Canada S7N 5E5
* Corresponding author. Tel.: +1-306-966-6294; fax: +1-306-966-6220 gopal{at}sask.usask.ca
Objective: Earlier, we reported that high insulin incubation in vitro leads to increased ETA receptor expression in cultured rat aortic smooth muscle cells (Diabetes 1998, 47: 934–944). Our later observation of enhanced endothelin-1 evoked vasoconstriction in aorta from the hyperinsulinemic obese Zucker rat indicated that this interaction might also be relevant in vivo. To further examine the relationship between insulinemia and endothelin, we characterized endothelin receptor expression and endothelin-1 peptide levels in vascular tissues and plasma from young and old obese Zucker rats. Methods: 12 and 40-week-old Zucker obese and lean rats were used. Plasma endothelin-1 levels and endothelin-1 peptide content in the mesenteric artery and in the thoracic aorta were examined by radioimmunoassay. Messenger RNA levels of endothelin-1 peptide and ETA and ETB receptors were examined in the aortic and mesenteric vessels using RT-PCR. Results: Obese rats from both age groups had significantly higher plasma levels of insulin (4–10 fold), total cholesterol (2–3 fold), triglycerides (10-fold), and glucose (
1.5 fold) than their lean counterparts. There was a trend toward worsening lipoproteinemia and glycemia, but improved insulinemia with age in the obese rats. In association with these changes, obese rats exhibited attenuated endothelin-1 peptide and preproET-1 mRNA levels, but conversely elevated ETA and ETB receptor mRNA levels in both aortic and mesenteric vessels. Conclusion: These data suggest that vascular tissue from the metabolically dysregulated obese Zucker rat exhibits attenuated endothelin-1 peptide production and elevated endothelin receptor levels. Since elevated insulin levels have been linked to increased endothelin receptor expression, it is plausible that hyperinsulinemia upregulates endothelin receptors contributing to elevated vasoconstrictor responses to endothelin-1 in this model of obesity and hypertension.
KEYWORDS Endothelins; Vasoactive agents
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. C. Eringa, C. D. A. Stehouwer, M. H. Roos, N. Westerhof, and P. Sipkema Selective resistance to vasoactive effects of insulin in muscle resistance arteries of obese Zucker (fa/fa) rats Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1134 - E1139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Bender and R. E. Klabunde Altered role of smooth muscle endothelin receptors in coronary endothelin-1 and {alpha}1-adrenoceptor-mediated vasoconstriction in Type 2 diabetes Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2281 - H2288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. An, R. Boyd, Y. Wang, X. Qiu, and H. D. Wang Endothelin-1 expression in vascular adventitial fibroblasts Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H700 - H708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. V. G. Katakam, J. A. Snipes, C. D. Tulbert, K. Mayanagi, A. W. Miller, and D. W. Busija Impaired endothelin-induced vasoconstriction in coronary arteries of Zucker obese rats is associated with uncoupling of [Ca2+]i signaling Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R145 - R153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Mather and S. Verma Function determines structure in the vasculature: lessons from insulin resistance Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R305 - R306. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cardillo, U. Campia, M. Iantorno, and J. A. Panza Enhanced Vascular Activity of Endogenous Endothelin-1 in Obese Hypertensive Patients Hypertension, January 1, 2004; 43(1): 36 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Treiber, P. Barbeau, G. Harshfield, H.-S. Kang, D. M. Pollock, J. S. Pollock, and H. Snieder Endothelin-1 Gene LYS198ASN Polymorphism and Blood Pressure Reactivity Hypertension, October 1, 2003; 42(4): 494 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Wilkes, A. Hevener, and J. Olefsky Chronic Endothelin-1 Treatment Leads to Insulin Resistance In Vivo Diabetes, August 1, 2003; 52(8): 1904 - 1909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Mather, B. Mirzamohammadi, A. Lteif, H. O. Steinberg, and A. D. Baron Endothelin Contributes to Basal Vascular Tone and Endothelial Dysfunction in Human Obesity and Type 2 Diabetes Diabetes, December 1, 2002; 51(12): 3517 - 3523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Miller, C. Tulbert, M. Puskar, and D. W. Busija Enhanced Endothelin Activity Prevents Vasodilation to Insulin in Insulin Resistance Hypertension, July 1, 2002; 40(1): 78 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. DAVIE, S. J. HALEEN, P. D. UPTON, J. M. POLAK, M. H. YACOUB, N. W. MORRELL, and J. WHARTON ETA and ETB Receptors Modulate the Proliferation of Human Pulmonary Artery Smooth Muscle Cells Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 398 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Asai, T. Ohkubo, T. Katsuya, J. Higaki, Y. Fu, M. Fukuda, A. Hozawa, M. Matsubara, H. Kitaoka, I. Tsuji, et al. Endothelin-1 Gene Variant Associates With Blood Pressure in Obese Japanese Subjects: The Ohasama Study Hypertension, December 1, 2001; 38(6): 1321 - 1324. [Abstract] [Full Text] [PDF]
|
|